Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.01 segundos. 
1.
8 p, 132.9 KB Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting / Muntañola, Ana (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Arguiñano, José M (Hospital Universitario de Navarra) ; Dávila, Julio (Complejo Asistencial de Ávila) ; de Villambrosia, Sonia González (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Carpio Segura, Cecilia del Carmen (Universitat Autònoma de Barcelona. Departament de Medicina) ; Jiménez-Ubieto, Ana (Hospital Universitario 12 de Octubre (Madrid)) ; Salar, Antonio (Universitat Pompeu Fabra)
Although rituximab is generally well-tolerated, infusion-related reactions (IRRs) are common with the initial dose when administered intravenously according to standard recommendations. To prevent IRRs, premedication and low-speed infusion rates have been recommended. [...]
2022 - 10.1111/cts.13450
Clinical and Translational Science, Vol. 16 (november 2022) , p. 305-312  
2.
8 p, 205.5 KB Edoxaban for the Long-Term Therapy of Venous Thromboembolism : Should the Criteria for Dose Reduction be Revised? / Camporese, Giuseppe (University Hospital of Padova (Pàdua, Itàlia)) ; Simioni, Paolo (University Hospital of Padova (Pàdua, Itàlia)) ; Di Micco, Pierpaolo (Ospedale Buon Consiglio Fatebenefratelli) ; Fernández-Capitán, Carmen (Hospital Universitario La Paz (Madrid)) ; Rivas, Agustina (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ; Font, Carme (Hospital Clínic i Provincial de Barcelona) ; Sahuquillo, Joan Carles (Hospital Municipal de Badalona) ; Villares, Paula (Hospital Universitario HM Sanchinarro (Madrid)) ; Prandoni, Paolo (University of Padua) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Edoxaban is used for venous thromboembolism (VTE) treatment. Real-life data are lacking about its use in long-term therapy. We aimed to assess the efficacy and the safety of edoxaban for long-term VTE treatment in a real-life setting. [...]
2020 - 10.1111/cts.12876
Clinical and Translational Science, Vol. 14 (october 2020) , p. 335-342  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.